A. Galid
Hanusch Hospital · 38 works · 1,563 citations · h-index 10
Top works
- A randomized double-blind multicenter phase III study offixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy
- Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group
- Impact of pretreatment thrombocytosis on survival in primary breast cancer
- Pathologic Complete Response With Six Compared With Three Cycles of Neoadjuvant Epirubicin Plus Docetaxel and Granulocyte Colony-Stimulating Factor in Operable Breast Cancer: Results of ABCSG-14
- Activity of T-DM1 in Her2-positive breast cancer brain metastases
- Axillary Lymph Node Metastases in Patients with Breast Carcinomas: Assessment with Nonenhanced versus USPIO-enhanced MR Imaging
- 6 vs. 3 cycles of epirubicin/docetaxel + G-CSF in operable breast cancer: results of ABCSG-14
- Orale Kontrazeptiva und Brustkrebs – ein kausaler Zusammenhang?
- Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer
- Current concepts and future directions in neoadjuvant chemotherapy of breast cancer
- 172P REACHAUT: Real-world study of first-line (1L) ribociclib (RIB) + endocrine therapy (ET) in HR+, HER2- metastatic breast cancer (MBC)
- 195P REACH AUT: Efficacy and safety of first-line (1L) ribociclib (RIB) + endocrine therapy (ET) in HR+, HER2- metastatic breast cancer (MBC) from a real-world (RW) study: 3rd interim analysis
- Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial
- First exercise group for Turkish breast cancer patients in Vienna – a pilot project to include Turkish migrants
- Estrogen replacement therapy in women with a history of breast cancer
- Mitteilungen aus Österreich
- Pharmacological modulation of local feedback mechanisms as a therapeutic approach in breast cancer treatment
- The oestrogen receptor and its selective modulators in gynaecological oncology
- Current practice of darbepoetin alfa in the management of haemoglobin levels in cancer patients undergoing chemotherapy – data from the CHOICE study
- A final analysis from the CHOICE study examining darbepoetin alfa use for chemotherapy-induced anaemia in current European clinical practice